CRL logo

Charles River Laboratories International Inc. (CRL)

$337.97

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CRL

Market cap

$16.19B

EPS

0.96

P/E ratio

--

Price to sales

3.6

Dividend yield

--

Beta

1.363465

Price on CRL

Previous close

$340.81

Today's open

$342.18

Day's range

$333.04 - $342.58

52 week range

$146.20 - $379.63

Profile about CRL

CEO

James C. Foster

Employees

19700

Headquarters

Wilmington, MA

Exchange

New York Stock Exchange

Shares outstanding

47917467

Issue type

Common Stock

CRL industries and sectors

Healthcare

Biotechnology & Life Sciences

News on CRL

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Jefferies Global Healthcare Conference.

news source

Business Wire • 6 hours ago

news preview

Ariel Small Cap Value Q3 2026 Portfolio Activity

Bar-code manufacturer Zebra Technologies was the top contributor during the quarter following a strong earnings report and raise to full-year guidance. Norwegian Cruise Line Holdings declined during the quarter as investors focused on weaker yield expectations, uneven booking trends and ongoing execution challenges. During the quarter, we acquired ADI Global Distribution following its spin-off from our existing holding, Resideo Technologies.

news source

Seeking Alpha • Nov 13, 2026

news preview

Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River has announced a series of strategic investments and operational enhancements across its global Microbial Solutions network.

news source

Business Wire • Nov 12, 2026

news preview

GMRS vs. CRL: Which Stock Should Value Investors Buy Now?

Investors interested in Medical Services stocks are likely familiar with GMR Solutions Inc. (GMRS) and Charles River Laboratories (CRL). But which of these two stocks offers value investors a better bang for their buck right now?

news source

Zacks Investment Research • Nov 12, 2026

news preview

Tigermed to Participate in the Privatization of Frontage Holdings Corporation and Divest Its Overseas Laboratory Services Business

HANGZHOU, China, Nov. 10, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (Stock Codes: 300347.SZ / 3347.HK, hereinafter referred to as "Tigermed"), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, today announced its proposal to participate in the privatization of its controlled subsidiary Frontage Holdings Corporation (Stock Code: 1521.HK, hereinafter referred to as "Frontage"), through its wholly-owned subsidiary Hongkong Tigermed Co., Limited.

news source

PRNewsWire • Nov 10, 2026

news preview

Charles River Laboratories to Acquire Frontage's Bioanalysis and DMPK Businesses

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Acquire Frontage's Bioanalysis and DMPK Businesses.

news source

Business Wire • Nov 9, 2026

news preview

Unlocking Charles River (CRL) International Revenues: Trends, Surprises, and Prospects

Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

news source

Zacks Investment Research • Nov 9, 2026

news preview

Here's Why Charles River Laboratories (CRL) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Nov 9, 2026

news preview

Charles River Laboratories International Q3 Earnings Call Highlights

Charles River Laboratories International NYSE: CRL raised its 2026 revenue and earnings outlook after third-quarter organic revenue growth accelerated to 4.7%, supported by demand for safety assessment and manufacturing testing services.

news source

MarketBeat • Nov 5, 2026

news preview

Charles River Laboratories Stock Pulls A Bear Move As Rats And Mice Retreat

Charles River Laboratories fell as researchers in North America pulled back on their spending on small animals used in lab testing.

news source

Investors Business Daily • Nov 4, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Charles River Laboratories International Inc.

Open an M1 investment account to buy and sell Charles River Laboratories International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CRL on M1